Therapeutics Acquisition Corp. (48) | License Agreements (1)

Recent Contracts

Exclusive License and Commercialization Agreement, dated December 16, 2020, by and between POINT Biopharma Inc., Canadian Molecular Probe Consortium, the Centre for Probe... (Filed With SEC on March 23, 2021)